A detailed history of Northern Trust Corp transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 771,368 shares of IDYA stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
771,368
Previous 640,665 20.4%
Holding current value
$21 Million
Previous $22.5 Million 8.64%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.37 - $43.05 $3.97 Million - $5.63 Million
130,703 Added 20.4%
771,368 $24.4 Million
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $96,339 - $121,818
-2,803 Reduced 0.44%
640,665 $22.5 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $1.11 Million - $1.53 Million
32,459 Added 5.31%
643,468 $28.2 Million
Q4 2023

Feb 13, 2024

BUY
$24.59 - $35.83 $1.22 Million - $1.78 Million
49,641 Added 8.84%
611,009 $21.7 Million
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $408,336 - $576,942
19,380 Added 3.58%
561,368 $15.1 Million
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $1.83 Million - $3.51 Million
137,485 Added 33.99%
541,988 $12.7 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $2,347 - $3,257
174 Added 0.04%
404,503 $5.55 Million
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $1.21 Million - $1.52 Million
83,821 Added 26.15%
404,329 $7.35 Million
Q3 2022

Nov 14, 2022

SELL
$9.24 - $15.79 $75,241 - $128,577
-8,143 Reduced 2.48%
320,508 $4.78 Million
Q2 2022

Aug 12, 2022

BUY
$8.28 - $13.88 $215,958 - $362,018
26,082 Added 8.62%
328,651 $4.54 Million
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $110,190 - $236,741
-9,856 Reduced 3.15%
302,569 $3.39 Million
Q4 2021

Feb 08, 2022

BUY
$20.95 - $26.88 $77,116 - $98,945
3,681 Added 1.19%
312,425 $7.39 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $826,236 - $1.3 Million
47,870 Added 18.35%
308,744 $7.87 Million
Q2 2021

Aug 13, 2021

BUY
$17.76 - $24.83 $1.61 Million - $2.25 Million
90,729 Added 53.32%
260,874 $5.48 Million
Q1 2021

May 12, 2021

SELL
$13.48 - $23.77 $408,444 - $720,231
-30,300 Reduced 15.12%
170,145 $4 Million
Q4 2020

Feb 11, 2021

BUY
$12.17 - $17.52 $364,406 - $524,601
29,943 Added 17.56%
200,445 $2.81 Million
Q3 2020

Nov 16, 2020

BUY
$11.22 - $14.46 $467,144 - $602,042
41,635 Added 32.31%
170,502 $2.14 Million
Q2 2020

Aug 14, 2020

BUY
$3.59 - $18.57 $462,632 - $2.39 Million
128,867 New
128,867 $1.83 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.31B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.